B

BioHarvest Sciences Inc. (BHST)

NGM – Real vaqt narxi. Valyuta: USD

3.84

+0.15 (4.07%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

B

BioHarvest Sciences Inc. (BHST)

NGM – Real vaqt narxi. Valyuta: USD

3.84

+0.15 (4.07%)

Yopilishda: May 12, 2026, 4:00 PM EDT

12.05.2026

BioHarvest Sciences wins $1.2M fragrance contract

BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) has secured a $1.2 million Stage 2 contract to develop a rare scent-producing plant compound for the global fragrance industry, marking a key step in the firm's push into a market the company values at $23 billion. The contract, awarded by a United Arab Emirates-based investment group, is part of a multi-stage development program for a fragrance raw material described as among the most valuable in the world, with premium grades fetching tens of thousands of dollars per kilogram.

12.05.2026

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Source plant is widely regarded as one of the most valuable fragrance raw materials in the world Stage 2 contract follows successful Stage 1 completion in March 2026 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 12, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has signed a $1.2 million-dollar Stage 2 contract as part of a multi-stage development program for a rare scent-producing plant used in the global fragrance industry. This scent is widely regarded as one of the most valuable fragrance raw materials in the world, with premium grades commanding prices exceeding tens of thousands of U.S. dollars per kilogram and demand growing across the Middle East, Asia, and luxury Western perfume markets.

07.05.2026

Will BioHarvest Sciences Inc. (BHST) Report Negative Earnings Next Week? What You Should Know

BioHarvest Sciences Inc. (BHST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

29.04.2026

BioHarvest Sciences names co-founder Rakib as CEO in leadership transition

BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Wednesday it has appointed co-founder Dr Zaki Rakib as CEO, consolidating leadership of its research, manufacturing, and operations under a unified structure as the botanical technology company sharpens its growth strategy. Rakib, who previously served as executive chairman, will take charge of the company's contract development and manufacturing organization (CDMO) division.

29.04.2026

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Ilan Sobel joins Board of Directors with focused mandate on D2C growth. Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role of Chief Executive Officer, Integrating R&D, Manufacturing, and Operations under the CDMO.

01.04.2026

BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call Transcript

31.03.2026

BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates

BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.17 per share a year ago.

Videolar

No Data

There is no data to display

Press-relizlar

12.05.2026

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Source plant is widely regarded as one of the most valuable fragrance raw materials in the world Stage 2 contract follows successful Stage 1 completion in March 2026 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 12, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has signed a $1.2 million-dollar Stage 2 contract as part of a multi-stage development program for a rare scent-producing plant used in the global fragrance industry. This scent is widely regarded as one of the most valuable fragrance raw materials in the world, with premium grades commanding prices exceeding tens of thousands of U.S. dollars per kilogram and demand growing across the Middle East, Asia, and luxury Western perfume markets.

29.04.2026

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Ilan Sobel joins Board of Directors with focused mandate on D2C growth. Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role of Chief Executive Officer, Integrating R&D, Manufacturing, and Operations under the CDMO.

31.03.2026

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

FY2025 Revenues were $34.5 million, up 37% vs previous year. The VINIA brand has achieved the No.1 resveratrol polyphenol position in the United States Market*.

31.03.2026

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

CDMO division has successfully completed Stage 1 under a development contract Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 31, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has successfully completed Stage 1 of a multi-stage development program for a rare scent-producing plant used in the global fragrance industry. The program is being conducted under a contract signed approximately one year ago, and represents what BioHarvest believes to be the first-ever successful creation of a stable cell culture for this rare and endangered fragrance plant.

Search stocks

BioHarvest Sciences Inc. (BHST)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

BioHarvest Sciences Inc. (BHST)

BioHarvest Sciences wins $1.2M fragrance contract

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Will BioHarvest Sciences Inc. (BHST) Report Negative Earnings Next Week? What You Should Know

BioHarvest Sciences names co-founder Rakib as CEO in leadership transition

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call Transcript

BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates

Videolar

No Data

Press-relizlar

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform